BJA Advance Access published online on October 14, 2004
British Journal of Anaesthesia, doi:10.1093/bja/aeh290
© 2004 by The Board of Management and Trustees of the British Journal of Anaesthesia
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Anaesthesiology, University Hospital Lausanne, Switzerland
* To whom correspondence should be addressed. E-mail: donat.spahn{at}chuv.hospvd.ch.
Careful assessment of risks and benefits has to precede each decision on allogeneic red blood cell (RBC) transfusion. Currently, a number of key issues in transfusion medicine are highly controversial, most importantly the influence of different transfusion thresholds on clinical outcome. The aim of this article is to review current evidence on blood transfusions, to highlight hot topics with respect to efficacy, outcome and risks, and to provide the reader with transfusion guidelines. In addition, a brief synopsis of transfusion alternatives will be given. Based on up-to-date information of current evidence, together with clinical knowledge and experience, the physician will be able to make transfusion decisions that bear the lowest risk for the patient.
Postgraduate Issue Review Article
Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Ludwig, J. Crawford, A. Osterborg, J. Vansteenkiste, D. H. Henry, A. Fleishman, K. Bridges, and J. A. Glaspy Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Induced Anemia J. Clin. Oncol., June 10, 2009; 27(17): 2838 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Slight, O. Nzewi, D. B. L. McClelland, and P. S. Mankad Red cell transfusion in elective cardiac surgery patients: where do we go from here? Br. J. Anaesth., March 1, 2009; 102(3): 294 - 296. [Full Text] [PDF] |
||||
![]() |
L. Bastit, A. Vandebroek, S. Altintas, B. Gaede, T. Pinter, T. S. Suto, T. W. Mossman, K. E. Smith, and J. F. Vansteenkiste Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia J. Clin. Oncol., April 1, 2008; 26(10): 1611 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Casati, A. D'Angelo, L. Barbato, D. Turolla, F. Villa, M. A. Grasso, A. Porta, and F. Guerra Perioperative management of four anaemic female Jehovah's Witnesses undergoing urgent complex cardiac surgery Br. J. Anaesth., September 1, 2007; 99(3): 349 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Murphy, E. Mango, V. Lucchetti, F. Battaglia, D. Catapano, C. A. Rogers, and G. D. Angelini A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 475 - 480.e8. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Walsh and E.-E.-D. Saleh Anaemia during critical illness Br. J. Anaesth., September 1, 2006; 97(3): 278 - 291. [Full Text] [PDF] |
||||
![]() |
J. M. Hunter The Recovery Period Br. J. Anaesth., July 1, 2005; 95(1): 1 - 2. [Full Text] [PDF] |
||||


